Search results
Novavax's New CEO Leads Vaccine Trial Success, and Big Layoffs Too
Motley Fool· 11 months agoNovavax (NASDAQ: NVAX) investors have been on edge ever since the company fell behind in the...
Novavax to pause RSV vaccine trial, assess pipeline
Yahoo Finance via AOL· 1 year agoNovavax (NVAX) is facing serious headwinds going into 2023 with the pandemic demand waning and new leadership changes, even as it celebrates a historic...
Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval
Yahoo Finance· 2 years agoNovavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first...
FDA signs off on Novavax COVID vaccine. Here's how it's different from other shots.
USA TODAY via Yahoo News· 7 months agoA third COVID-19 vaccine, made by Novavax, will soon be available in pharmacies and doctor's...
Novavax's updated COVID vaccine is here. What to know about the shot.
Yahoo Life· 6 months agoUnlike Moderna and Pfizer's mRNA vaccines, the Novavax vaccine utilizes a protein-based approach....
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 3 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
Updated non-mrna COVID vaccine Novavax doses cost $130. What to know about coronavirus vax
Pensacola News Journal via Yahoo News· 6 months agoThe U.S. just approved the updated non-mRNA COVID-19 vaccine made by Novavax for use and millions of...
A ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon...
Fortune via Yahoo Finance· 2 years agoThe U.S. Food and Drug Administration (FDA) on Wednesday approved the COVID-19 vaccine from American...
FDA authorizes Novavax’s COVID-19 vaccine
The Today Show via AOL· 2 years agoThe Food and Drug Administration on Wednesday authorized Novavax’s protein-based COVID-19 vaccine for adults, providing Americans with an alternative to...
Novavax, the non-mRNA vaccine against COVID-19 that had a clinical trial in Spokane, has cleared a...
The Spokesman-Review, Spokane, Wash. via Yahoo News· 2 years agoJun. 9—A highly anticipated traditional vaccine to fight COVID-19 has experts hoping it will be an attractive option for people hesitant of getting the shot from a brand that uses mRNA technology ...
